Figure 5 - full size

 

Figure 5.
(A) Overlay of LT1009 and Q425 anti-CD4 antibody Fab crystal structures illustrates their overall homology and different Ca^2+ binding sites. LT1009 is colored as in previous figures while the Q425 light chain is cyan and the heavy chain fragment is blue. For the sake of clarity, S1P has been removed from the LT1009 Fab model. (B) A close up view of Ca^2+ binding sites in the 2 models reveals conservation of metal coordinating side chains and the different conformations of CDR-H3. (C) Schematic representation of a possible mechanism of S1P binding by LT1009. In its unbound conformation, the light chain (labeled ā€œLā€ in the figure) binds one Ca^2+ at a site similar to that observed in the Q425 antibody structures. S1P binding introduces conformational changes that disrupt the original Ca^2+ binding motif as well as potentially introducing one additional Ca^2+. The phosphate group of S1P then combines with 2 Ca^2+ to produce the extremely stable Ca^2+ coordination complex observed in the S1P:LT1009 Fab complex crystal structure.